| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/30/1999 | CA2325634A1 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease |
| 09/30/1999 | CA2325631A1 Therapy of estrogen-associated disorders |
| 09/30/1999 | CA2325588A1 Imidazolone anorectic agents: i. acyclic derivatives |
| 09/30/1999 | CA2325587A1 Imidazolone anorectic agents: ii. phenyl derivatives |
| 09/30/1999 | CA2325585A1 Inflammatory mediator antagonists |
| 09/30/1999 | CA2325472A1 Imidazolone anorectic agents: iii. heteroaryl derivatives |
| 09/30/1999 | CA2324999A1 Methods for decreasing .beta.-amyloid protein |
| 09/30/1999 | CA2324610A1 Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate |
| 09/30/1999 | CA2324566A1 Pharmaceutical composition containing a cysteine protease inhibitor for prophylaxis and therapy of brain tissue impairment |
| 09/30/1999 | CA2324494A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 09/30/1999 | CA2324350A1 Cardiac-derived stem cells |
| 09/30/1999 | CA2324347A1 Benzoates derivatives for inhibiting angiogenesis |
| 09/30/1999 | CA2324266A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors |
| 09/30/1999 | CA2323782A1 Methods for prevention and treatment of cancer |
| 09/30/1999 | CA2323063A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 09/30/1999 | CA2322779A1 Glycosyl sulfotransferase-3 |
| 09/30/1999 | CA2320204A1 Use of cabergoline in the treatment of restless legs syndrome |
| 09/30/1999 | CA2267047A1 Derivatives of phenoxy acetic acid and phenoxymethyl tetrazole having antitumor activity |
| 09/29/1999 | EP0944725A1 Phosphodiesterase 8a |
| 09/29/1999 | EP0944719A1 Tryparedoxin peroxidase |
| 09/29/1999 | EP0944715A1 Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/29/1999 | EP0944645A1 INHIBITORS OF INTERLEUKIN-1beta CONVERTING ENZYME |
| 09/29/1999 | EP0944639A1 Synthetic glycoamines, methods for their use that affect cell |
| 09/29/1999 | EP0944630A1 Xanthines and their therapeutic use |
| 09/29/1999 | EP0944629A1 Biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 09/29/1999 | EP0944628A1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 09/29/1999 | EP0944626A1 Tropane derivatives and method for their synthesis |
| 09/29/1999 | EP0944622A1 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944620A1 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944619A1 Novel integrin receptor antagonists |
| 09/29/1999 | EP0944618A1 Novel n-benzenesulphonyl-l-proline derivatives, method for preparing and therapeutic use |
| 09/29/1999 | EP0944616A1 Bicyclic aryl carboxamides and their therapeutic use |
| 09/29/1999 | EP0944614A1 Benzothiophenecarboxamide derivatives and pgd2 antagonists comprising them |
| 09/29/1999 | EP0944612A1 N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 09/29/1999 | EP0944611A1 Dimesylate salts of neuropeptide y ligands |
| 09/29/1999 | EP0944610A1 Asymmetric synthesis of benzoxazinones |
| 09/29/1999 | EP0944602A1 Apo b-secretion/mtp inhibitory amides |
| 09/29/1999 | EP0944601A1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 09/29/1999 | EP0944599A1 Triarylethanes useful as pde iv inhibitors |
| 09/29/1999 | EP0944597A1 Metalloproteinase inhibitors |
| 09/29/1999 | EP0944596A1 Seco precursors of cyclopropylindolines and their use as prodrugs |
| 09/29/1999 | EP0944595A1 5-cyclo indole compounds as 5-ht1d receptor ligands |
| 09/29/1999 | EP0944594A1 Inhibitors of the enzymatic activity of psa |
| 09/29/1999 | EP0944587A1 Metalloproteinase inhibitors |
| 09/29/1999 | EP0944584A1 Benzamidoaldehydes and their use as cysteine protease inhibitors |
| 09/29/1999 | EP0944582A1 Ketobenzamides as calpain inhibitors |
| 09/29/1999 | EP0944399A2 Covalent polar lipid conjugates for targeting |
| 09/29/1999 | EP0944395A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye |
| 09/29/1999 | EP0944393A1 Use of peptides for improving the incorporation of skin grafts |
| 09/29/1999 | EP0944388A2 Inhibitors of farnesyl-protein transferase |
| 09/29/1999 | EP0944387A1 Inhibitors of farnesyl-protein transferase |
| 09/29/1999 | EP0944311A1 Heregulin antagonists and methods for their use |
| 09/29/1999 | EP0791005B1 Smooth muscle cell proliferation inhibitors |
| 09/29/1999 | CN1230220A Therapy for 'alpha'-galactosidase deficiency |
| 09/29/1999 | CN1230196A Modified aminoacids, pharmaceuticals containing these compounds and method for their prodn. |
| 09/29/1999 | CN1230195A Treatment of immune disorders |
| 09/29/1999 | CN1230187A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230186A Pyrazolopyridine compound and pharmaceutical use thereof |
| 09/29/1999 | CN1230185A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 09/29/1999 | CN1230184A Arylamino fused pyridines and pyrimidines |
| 09/29/1999 | CN1230180A D4 receptor selectivity piperazine derivatives |
| 09/29/1999 | CN1230179A Prepn. of 1-butyl-4-piperidinylmethylamine |
| 09/29/1999 | CN1230178A Polydithiocarbamate-containing macromolecules and use thereof for therapeutic and diagnostic applications |
| 09/29/1999 | CN1230122A Medical compsns. |
| 09/29/1999 | CN1230120A Compounds that inhibit interaction between signal-transducing proteins and GLGF(PDZ/DHR) domain and uses thereof |
| 09/29/1999 | CN1045294C Method for prepn. of indole derivatives |
| 09/29/1999 | CN1045290C Method for preparation of chelans possesing ortho ligating functionality and complexes |
| 09/28/1999 | US5959113 Reacting a diketone derivative with an aldehyde derivative; administering to treat atherosclerosis, psoriasis, alopecia and tumors |
| 09/28/1999 | US5959109 Compounds and methods for increasing endogenous levels of corticotropin-releasing factor |
| 09/28/1999 | US5959079 CREBA isoform |
| 09/28/1999 | US5959075 Testis-specific insulin homolog polypeptides |
| 09/28/1999 | US5958978 Specific cyclooxygenase 2 inhibitor and anti-inflammatory agent |
| 09/28/1999 | US5958975 Antiodor, antimicrobial and preservative compositions and methods of using same |
| 09/28/1999 | US5958971 Chemical compounds |
| 09/28/1999 | US5958969 Osteoporosis |
| 09/28/1999 | US5958968 Cardiovascular disorders; kidney dieases |
| 09/28/1999 | US5958960 Excitatory amino acid receptor modulators |
| 09/28/1999 | US5958958 1,2,4-oxa diazolino and 1,24-oxa diazolidion heterocycles as useful nitric oxide synthase inhibitors |
| 09/28/1999 | US5958956 Aromatic carboxylic acid esters |
| 09/28/1999 | US5958953 Substituted indazole derivatives |
| 09/28/1999 | US5958943 A!-anellated pyrrole derivatives and their use in pharmacology |
| 09/28/1999 | US5958941 Use of L-carnitine and its alkanoyl derivatives for reducing the toxic effects of cyclosporin-A and other immunosuppressant drugs |
| 09/28/1999 | US5958936 For inducing antiandrogenic activity in warm-blooded animals, including humans |
| 09/28/1999 | US5958932 Antitumor agent |
| 09/28/1999 | US5958931 Phenyl-substituted 5H-thiazolo 3,2-A!pyrimidine derivative glutamate receptor antagonists |
| 09/28/1999 | US5958927 Psychological and nervous system disorders |
| 09/28/1999 | US5958926 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses |
| 09/28/1999 | US5958924 Hypotensive agents, cardiovascular disorders, antiischemic agents, restenosis, anticoalugants, respiratory system disorders |
| 09/28/1999 | US5958918 Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds |
| 09/28/1999 | US5958917 Benzofluorene compounds, intermediates, compositions, and methods |
| 09/28/1999 | US5958910 Use of N-(4-aryl-thiazol-2-yl)-sulfonamides |
| 09/28/1999 | US5958908 Sodium alendronate preparation for local administration |
| 09/28/1999 | US5958905 Phosphoramidates, phosphinic amides and related compounds and the use thereof to modulate the activity of endothelin |
| 09/28/1999 | US5958903 Cholinesterase inhibitors |
| 09/28/1999 | US5958902 Method and composition for treating sleep apnea |
| 09/28/1999 | US5958897 Method of treating sinusitis with uridine triphosphates and related compounds |
| 09/28/1999 | US5958882 Compounds that inhibit T cell proliferation and methods using the same |
| 09/28/1999 | US5958772 Antisense inhibition of cellular inhibitor of apoptosis-1 expression |
| 09/28/1999 | US5958767 Engraftable human neural stem cells |
| 09/28/1999 | US5958726 Polynucleotide sequence of clone h84924 accession number atcc 98028; has signal sequence; for diagnosis and treatment of related diseases |